I agree that this site is using cookies. You can find further informations here.
X
Skert, C
24  results:
Search for persons X
?
1

Bloodstream infections in haematological cancer patients co..:

on behalf of SEIFEM Group ; Cattaneo, C. ; Di Blasi, R....
Annals of Hematology.  97 (2018)  9 - p. 1717-1726 , 2018
Link: https://doi.org/10.1007/..
 
?
2

Circulating endothelial cell count: a reliable marker of en..:

Almici, C ; Skert, C ; Bruno, B...
Bone Marrow Transplantation.  52 (2017)  12 - p. 1637-1642 , 2017
Link: https://doi.org/10.1038/..
 
?
3

Early consolidation with high-dose therapy and autologous s..:

Re, A ; Gini, G ; Rupolo, M...
Bone Marrow Transplantation.  53 (2017)  2 - p. 228-230 , 2017
Link: https://doi.org/10.1038/..
 
?
4

Emerging resistant bacteria strains in bloodstream infectio..:

Cattaneo, Chiara ; Zappasodi, P. ; Mancini, V....
Annals of Hematology.  95 (2016)  12 - p. 1955-1963 , 2016
Link: https://doi.org/10.1007/..
 
?
5

Managing chronic myeloid leukaemia in the elderly with inte..:

Russo, D ; Malagola, M ; Skert, C...
Blood Cancer Journal.  5 (2015)  9 - p. e347-e347 , 2015
Link: https://doi.org/10.1038/..
 
?
6

A specific Toll‐like receptor profile on T lymphocytes and ..:

Skert, C. ; Fogli, M. ; Garrafa, E....
Transplant Infectious Disease.  16 (2014)  5 - p. 697-712 , 2014
Link: https://doi.org/10.1111/..
 
?
7

216 Azacitidine low-dose schedule in low-risk myelodysplast..:

Fill, C. ; Finelli, C. ; Gobbi, M....
Leukemia Research.  35 (2011)  - p. S84-S85 , 2011
Link: https://doi.org/10.1016/..
 
?
8

P153 Clinical effects of 5-azacitidine five days/monthly sc..:

Fili, C. ; Bergonzi, C. ; Skert, C....
Leukemia Research.  31 (2007)  - p. S124 , 2007
Link: https://doi.org/10.1016/..
 
?
9

Helicobacter pylori infection and idiophatic thrombocytopen..:

Brosolo, P. ; Grimaz, S. ; Skert, C....
Digestive and Liver Disease.  32 (2000)  - p. A141 , 2000
Link: https://doi.org/10.1016/..
 
?
10

Busulfan or Treosulfan Conditioning Platform for Allogeneic..:

Malagola M ; Polverelli N ; Martino M...
volume:9.  , 2023
Link: https://hdl.handle.net/1..
 
?
11

Busulfan or Treosulfan Conditioning Platform for Allogeneic..:

Malagola M ; Polverelli N ; Martino M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000943227800003.  , 2023
Link: https://hdl.handle.net/2..
 
?
12

GITMO Registry Study on Allogeneic Transplantation in Patie..:

Malagola M ; Polverelli N ; Rubini V...
info:eu-repo/semantics/altIdentifier/pmid/34818581.  , 2022
Link: http://hdl.handle.net/11..
 
?
13

GITMO Registry Study on Allogeneic Transplantation in Patie..:

Malagola M ; Polverelli N ; Rubini V...
journal:TRANSPLANTATION AND CELLULAR THERAPY.  , 2021
Link: http://hdl.handle.net/11..
 
?
14

Mrd‐based therapeutic decisions in genetically defined subs..:

Tosi M ; Spinelli O ; Leoncin M...
info:eu-repo/semantics/altIdentifier/pmid/33925541.  , 2021
Link: http://hdl.handle.net/24..
 
?
15

Counting circulating endothelial cells in allo-HSCT: an ad ..:

Almici C ; Neva A ; Skert C...
info:eu-repo/semantics/altIdentifier/pmid/30643152.  , 2019
Link: http://hdl.handle.net/23..
 
1-15